WEST PHARMACEUTICAL SERVICES (WST)
US9553061055 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.832B 31.89% | 2.887B 1.95% | 2.95B 2.18% | 2.913B -1.25% | 3.09B 6.08% | 3.366B 8.93% | 3.658B 8.67% | 3.986B 8.97% | |
| EBITDA YoY % growth | 879.5M 66.95% | 875.5M -0.45% | 842.4M -3.78% | 724.64M -13.98% | 848.5M 17.09% | 980.31M 15.53% | 1.054B 7.52% | 1.603B 52.09% | |
| EBIT YoY % growth | 757.2M 81.28% | 754.9M -0.30% | 705.1M -6.60% | 569.4M -19.25% | 677.74M 19.03% | 794.56M 17.24% | 915.06M 15.17% | 1.03B 12.56% | |
| Operating Margin | 26.74% | 26.15% | 23.90% | 19.55% | 21.93% | 23.61% | 25.02% | 25.84% | |
| EPS YoY % growth | 8.61 81.26% | 8.57 -0.46% | 8.08 -5.72% | 6.66 -17.57% | 7.59 14.00% | 8.96 18.03% | 11.16 24.54% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.73 -5.42% | 1.70 8.77% | 1.84 20.93% | 1.99 7.37% | 2.09 20.59% | 2.05 20.54% | 2.19 19.23% | 2.16 8.56% | 2.28 9.11% |
| Revenue Q2Q % growth | 747.37M 2.10% | 739.49M 6.34% | 764.71M 8.92% | 791.59M 5.98% | 805.99M 7.84% | 811.49M 9.74% | 848.41M 10.95% | 834.07M 5.37% | 862.23M 6.98% |
| EBITDA Q2Q % growth | 194.8M -36.36% | 193.06M 20.51% | 207.81M 2.37% | 218.95M -21.41% | 231.03M 18.60% | 227.97M 18.08% | 242.02M 16.46% | 238.2M 8.79% | 251.11M 8.69% |
| EBIT Q2Q % growth | 153.64M -8.98% | 150.99M 21.18% | 165.11M 28.49% | 175.38M 7.00% | 186.85M 21.62% | 184.42M 22.14% | 198.06M 19.96% | 193.87M 10.54% | 205.97M 10.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.85 -14.35% | 1.52 | 0.33 | 22.11% |
| Q2 2024 Q2Q % growth | 1.52 -27.96% | 1.76 | -0.24 | -13.56% |
| Q1 2024 Q2Q % growth | 1.56 -21.21% | 1.29 | 0.27 | 21.26% |
| Q4 2023 Q2Q % growth | 1.83 3.39% | 1.80 | 0.03 | 1.93% |
| Q3 2023 Q2Q % growth | 2.16 6.40% | 1.87 | 0.29 | 15.21% |
| Q2 2023 Q2Q % growth | 2.11 -14.57% | 1.95 | 0.16 | 8.45% |
| Q1 2023 Q2Q % growth | 1.98 -13.91% | 1.69 | 0.29 | 17.48% |
| Q4 2022 Q2Q % growth | 1.77 -13.24% | 1.39 | 0.38 | 27.34% |
| Q3 2022 Q2Q % growth | 2.03 -1.46% | 2.14 | -0.11 | -5.19% |
| Q2 2022 Q2Q % growth | 2.47 0.41% | 2.24 | 0.23 | 10.49% |
| Q1 2022 Q2Q % growth | 2.30 12.20% | 2.14 | 0.16 | 7.25% |
| Q4 2021 Q2Q % growth | 2.04 52.24% | 1.93 | 0.11 | 5.47% |
| Q3 2021 Q2Q % growth | 2.06 79.13% | 1.81 | 0.25 | 13.52% |
| Q2 2021 Q2Q % growth | 2.46 96.80% | 1.76 | 0.70 | 39.98% |
| Q1 2021 Q2Q % growth | 2.05 102.97% | 1.45 | 0.60 | 41.77% |
| Q4 2020 Q2Q % growth | 1.34 63.41% | 1.14 | 0.20 | 17.93% |
| Q3 2020 Q2Q % growth | 1.15 45.57% | 1.01 | 0.14 | 14.15% |
| Q2 2020 Q2Q % growth | 1.25 40.45% | 0.92 | 0.33 | 36.38% |
| Q1 2020 Q2Q % growth | 1.01 36.49% | 0.83 | 0.18 | 21.65% |
| Q4 2019 Q2Q % growth | 0.82 12.33% | 0.73 | 0.09 | 12.45% |
| Q3 2019 Q2Q % growth | 0.79 3.95% | 0.72 | 0.07 | 10.48% |
| Q2 2019 Q2Q % growth | 0.89 27.14% | 0.73 | 0.16 | 21.71% |
| Q1 2019 Q2Q % growth | 0.74 19.35% | 0.66 | 0.08 | 11.57% |
| Q4 2018 Q2Q % growth | 0.73 | 0.73 | 0.00 | 0.39% |
| Q3 2018 Q2Q % growth | 0.76 | 0.71 | 0.05 | 7.09% |
| Q2 2018 Q2Q % growth | 0.70 | 0.67 | 0.03 | 3.96% |
| Q1 2018 Q2Q % growth | 0.62 | 0.64 | -0.02 | -3.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 746.9M -0.07% | 716.71M | 30.19M | 4.21% |
| Q2 2024 Q2Q % growth | 702.1M -6.86% | 736.64M | -34.54M | -4.69% |
| Q1 2024 Q2Q % growth | 695.4M -2.96% | 677.32M | 18.08M | 2.67% |
| Q4 2023 Q2Q % growth | 732M 3.29% | 746.86M | -14.86M | -1.99% |
| Q3 2023 Q2Q % growth | 747.4M 8.81% | 757.81M | -10.41M | -1.37% |
| Q2 2023 Q2Q % growth | 753.8M -2.27% | 763.26M | -9.46M | -1.24% |
| Q1 2023 Q2Q % growth | 716.6M -0.47% | 705.17M | 11.43M | 1.62% |
| Q4 2022 Q2Q % growth | 708.7M -3.02% | 663.74M | 44.96M | 6.77% |
| Q3 2022 Q2Q % growth | 686.9M -2.77% | 738.23M | -51.33M | -6.95% |
| Q2 2022 Q2Q % growth | 771.3M 6.59% | 764.77M | 6.53M | 0.85% |
| Q1 2022 Q2Q % growth | 720M 7.35% | 728.13M | -8.13M | -1.12% |
| Q4 2021 Q2Q % growth | 730.8M 25.96% | 717.3M | 13.5M | 1.88% |
| Q3 2021 Q2Q % growth | 706.5M 28.92% | 693.96M | 12.54M | 1.81% |
| Q2 2021 Q2Q % growth | 723.6M 37.25% | 676.08M | 47.52M | 7.03% |
| Q1 2021 Q2Q % growth | 670.7M 36.46% | 617.51M | 53.19M | 8.61% |
| Q4 2020 Q2Q % growth | 580.2M 23.29% | 549.11M | 31.09M | 5.66% |
| Q3 2020 Q2Q % growth | 548M 20.15% | 515.25M | 32.75M | 6.36% |
| Q2 2020 Q2Q % growth | 527.2M 12.24% | 501.05M | 26.15M | 5.22% |
| Q1 2020 Q2Q % growth | 491.5M 10.82% | 471.46M | 20.04M | 4.25% |
| Q4 2019 Q2Q % growth | 470.6M 11.38% | 456.04M | 14.56M | 3.19% |
| Q3 2019 Q2Q % growth | 456.1M 5.65% | 455.45M | 650K | 0.14% |
| Q2 2019 Q2Q % growth | 469.7M 4.96% | 465.01M | 4.69M | 1.01% |
| Q1 2019 Q2Q % growth | 443.5M 6.69% | 434.4M | 9.1M | 2.09% |
| Q4 2018 Q2Q % growth | 422.5M | 436.29M | -13.79M | -3.16% |
| Q3 2018 Q2Q % growth | 431.7M | 432.69M | -990K | -0.23% |
| Q2 2018 Q2Q % growth | 447.5M | 428.73M | 18.77M | 4.38% |
| Q1 2018 Q2Q % growth | 415.7M | 408.25M | 7.45M | 1.82% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -25.77% | 0.21% | 1.27% |
| Revenue | 0% | -7.8% | 0.03% | 0.38% |